ARCHIVES

NCI To Begin Study of Augmentation Mammoplasty This Fall

This article is from The Cancer Letter archive.

Vol. 18 No. 19 | May 8, 1992

Download PDF Visit The Full Archive

Related Articles

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009

NCI Formaldehyde Finding Criticized

March 7, 1986

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Hydridoma Cell Lines Available

March 5, 1982

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.

June 4, 2004